glutathione recycling and autophagy Frontiers Glutathione Participation in the Prevention
Description
For instance, for a MASLD patient characterized by enrichment of a specific pathogen and lack of SCFAs, the treatment plan might include phages targeting that pathogen, supplementation with specific butyrate-producing strains, and dietary guidance rich in fermentable fibers
H 2 S oxidation by nanodisc-embedded human sulfide quinone oxidoreductase
Our study also reveals a novel treatment option of DM-related arrhythmias by using either an IL-1 receptor antagonist (anakinra) or a NLRP3 inhibitor (MCC-950)
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
